These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 8675271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined Antihypertensive Therapies That Increase Expression of Cardioprotective Biomarkers Associated With the Renin-Angiotensin and Kallikrein-Kinin Systems.
    Lezama-Martinez D, Flores-Monroy J, Fonseca-Coronado S, Hernandez-Campos ME, Valencia-Hernandez I, Martinez-Aguilar L.
    J Cardiovasc Pharmacol; 2018 Dec; 72(6):291-295. PubMed ID: 30422889
    [Abstract] [Full Text] [Related]

  • 3. Correlation of renin angiotensin system (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension.
    Gupta S, Chattopadhyaya I, Agrawal BK, Sehajpal PK, Goel RK.
    J Postgrad Med; 2015 Dec; 61(1):21-6. PubMed ID: 25511213
    [Abstract] [Full Text] [Related]

  • 4. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y.
    Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
    [Abstract] [Full Text] [Related]

  • 5. Regulation of the gene expression of type-1 angiotensin II receptor in spontaneously hypertensive rats.
    Kitami Y, Okura T, Wakamiya R, Marumoto K, Iwata T, Hiwada K.
    Blood Press Suppl; 1992 Sep; 3():12-6. PubMed ID: 1343280
    [Abstract] [Full Text] [Related]

  • 6. Pharmacogenetics of antihypertensive treatment.
    Arnett DK, Claas SA, Glasser SP.
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [Abstract] [Full Text] [Related]

  • 7. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH.
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [Abstract] [Full Text] [Related]

  • 8. Association of angiotensin II type 1 receptor polymorphism with resistant essential hypertension.
    Szombathy T, Szalai C, Katalin B, Palicz T, Romics L, Császár A.
    Clin Chim Acta; 1998 Jan 12; 269(1):91-100. PubMed ID: 9498106
    [Abstract] [Full Text] [Related]

  • 9. Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor.
    Li X, Du Y, Du Y, Huang X.
    J Cardiovasc Pharmacol Ther; 2003 Mar 12; 8(1):25-30. PubMed ID: 12652327
    [Abstract] [Full Text] [Related]

  • 10. Renin angiotensin system blockage associates with insertion/deletion polymorphism of angiotensin-converting enzyme in patients with hypertensive emergency.
    Vilela-Martin JF, Vaz-de-Melo RO, Cosenso-Martin LN, Kuniyoshi CH, Yugar-Toledo JC, Pinhel MA, de Souza GF, Souza DR, Pimenta E, Moreno H, Cipullo JP.
    DNA Cell Biol; 2013 Sep 12; 32(9):541-8. PubMed ID: 23869738
    [Abstract] [Full Text] [Related]

  • 11. Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients.
    Yu H, Zhang Y, Liu G.
    Hypertens Res; 2003 Nov 12; 26(11):881-6. PubMed ID: 14714579
    [Abstract] [Full Text] [Related]

  • 12. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals.
    Benetos A, Cambien F, Gautier S, Ricard S, Safar M, Laurent S, Lacolley P, Poirier O, Topouchian J, Asmar R.
    Hypertension; 1996 Dec 12; 28(6):1081-4. PubMed ID: 8952600
    [Abstract] [Full Text] [Related]

  • 13. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J.
    Clin Endocrinol (Oxf); 2002 Oct 12; 57(4):457-65. PubMed ID: 12354127
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antihypertensive effect of angiotensin-converting enzyme inhibitory peptide RVPSL on spontaneously hypertensive rats by regulating gene expression of the renin-angiotensin system.
    Yu Z, Yin Y, Zhao W, Chen F, Liu J.
    J Agric Food Chem; 2014 Jan 29; 62(4):912-7. PubMed ID: 24404915
    [Abstract] [Full Text] [Related]

  • 16. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension.
    Giner V, Poch E, Bragulat E, Oriola J, González D, Coca A, De La Sierra A.
    Hypertension; 2000 Jan 29; 35(1 Pt 2):512-7. PubMed ID: 10642351
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of angiotensin II AT1 receptor blockers in the treatment of arterial hypertension.
    Contreras F, de la Parte MA, Cabrera J, Ospino N, Israili ZH, Velasco M.
    Am J Ther; 2003 Jan 29; 10(6):401-8. PubMed ID: 14624277
    [Abstract] [Full Text] [Related]

  • 19. Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme?
    de Gasparo M, Levens N.
    Pharmacol Toxicol; 1998 Jun 29; 82(6):257-71. PubMed ID: 9677617
    [Abstract] [Full Text] [Related]

  • 20. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
    Sim JJ, Bhandari SK, Shi J, Kalantar-Zadeh K, Rasgon SA, Sealey JE, Laragh JH.
    Am J Hypertens; 2012 Mar 29; 25(3):379-88. PubMed ID: 22158065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.